{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:53:13Z","timestamp":1767855193378,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/leu.2015.153","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T06:41:47Z","timestamp":1435128107000},"page":"2307-2316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of p38\u03b1\/\u03b2 inhibition on acute lymphoblastic leukemia proliferation and survival in vivo"],"prefix":"10.1038","volume":"29","author":[{"given":"A","family":"Alsadeq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Strube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Carlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Vokuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Loges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Aguirre-Ghiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Trauzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Cario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"Schewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"BFleu2015153_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/leu.2009.257","volume":"24","author":"A Moricke","year":"2010","unstructured":"Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010; 24: 265\u2013284.","journal-title":"Leukemia"},{"key":"BFleu2015153_CR2","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1182\/blood-2012-02-265884","volume":"120","author":"F Locatelli","year":"2012","unstructured":"Locatelli F, Schrappe M, Bernardo ME, Rutella S . How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012; 120: 2807\u20132816.","journal-title":"Blood"},{"key":"BFleu2015153_CR3","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3324\/haematol.2011.059584","volume":"97","author":"V Gandemer","year":"2012","unstructured":"Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G et al. Excellent prognosis of late relapses of ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol. Haematologica 2012; 97: 1743\u20131750.","journal-title":"Haematologica"},{"key":"BFleu2015153_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2006.06443.x","volume":"136","author":"H Yasui","year":"2007","unstructured":"Yasui H, Hideshima T, Ikeda H, Jin J, Ocio EM, Kiziltepe T et al. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase\/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth. Br J Haematol 2007; 136: 414\u2013423.","journal-title":"Br J Haematol"},{"key":"BFleu2015153_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.leukres.2009.05.024","volume":"34","author":"J Wen","year":"2010","unstructured":"Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L et al. Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. Leukemia Res 2010; 34: 85\u201392.","journal-title":"Leukemia Res"},{"key":"BFleu2015153_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.exphem.2008.11.002","volume":"37","author":"BA Nijmeijer","year":"2009","unstructured":"Nijmeijer BA, Szuhai K, Goselink HM, van Schie ML, van der Burg M, de Jong D et al. Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors. Exp Hematol 2009; 37: 376\u2013385.","journal-title":"Exp Hematol"},{"key":"BFleu2015153_CR7","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.4161\/cc.8.18.9545","volume":"8","author":"SS Gaundar","year":"2009","unstructured":"Gaundar SS, Bradstock KF, Bendall LJ . p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell Cycle 2009; 8: 2975\u20132983.","journal-title":"Cell Cycle"},{"key":"BFleu2015153_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR . Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429: 403\u2013417.","journal-title":"Biochem J"},{"key":"BFleu2015153_CR9","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1074\/jbc.M106640200","volume":"277","author":"A Verma","year":"2002","unstructured":"Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A et al. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 2002; 277: 7726\u20137735.","journal-title":"J Biol Chem"},{"key":"BFleu2015153_CR10","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-10-2574","volume":"17","author":"MS Sosa","year":"2011","unstructured":"Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA . ERK1\/2 and p38alpha\/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res 2011; 17: 5850\u20135857.","journal-title":"Clin Cancer Res"},{"key":"BFleu2015153_CR11","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-08-3820","volume":"69","author":"AP Adam","year":"2009","unstructured":"Adam AP, George A, Schewe D, Bragado P, Iglesias BV, Ranganathan AC et al. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res 2009; 69: 5664\u20135672.","journal-title":"Cancer Res"},{"key":"BFleu2015153_CR12","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/j.febslet.2006.05.031","volume":"580","author":"J Lu","year":"2006","unstructured":"Lu J, Quearry B, Harada H . p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 2006; 580: 3539\u20133544.","journal-title":"FEBS Lett"},{"key":"BFleu2015153_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s12032-010-9641-x","volume":"28","author":"YN Zhao","year":"2011","unstructured":"Zhao YN, Guo X, Ma ZG, Gu L, Ge J, Li Q . Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells. Med Oncol 2011; 28: 1609\u20131617.","journal-title":"Med Oncol"},{"key":"BFleu2015153_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4161\/cc.6.5.3921","volume":"6","author":"L Zhou","year":"2007","unstructured":"Zhou L, Opalinska J, Verma A . p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle 2007; 6: 534\u2013537.","journal-title":"Cell Cycle"},{"key":"BFleu2015153_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3324\/haematol.10621","volume":"92","author":"J Juarez","year":"2007","unstructured":"Juarez J, Baraz R, Gaundar S, Bradstock K, Bendall L . Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia. Haematologica 2007; 92: 450\u2013459.","journal-title":"Haematologica"},{"key":"BFleu2015153_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2141.2009.07648.x","volume":"145","author":"JG Juarez","year":"2009","unstructured":"Juarez JG, Thien M, Dela Pena A, Baraz R, Bradstock KF, Bendall LJ . CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK. Br J Haematol 2009; 145: 491\u2013499.","journal-title":"Br J Haematol"},{"key":"BFleu2015153_CR17","first-page":"p2","volume-title":"Guide to Leukemia-Lymphoma Cell Lines","author":"HG Drexler","year":"2010","unstructured":"Drexler HG . Guide to Leukemia-Lymphoma Cell Lines. Electronic Book, DSMZ: : Braunschweig, Germany, 2010, p2."},{"key":"BFleu2015153_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0968-0004(00)01595-4","volume":"25","author":"AR Nebreda","year":"2000","unstructured":"Nebreda AR, Porras A . p38 MAP kinases: beyond the stress response. Trends Biochem Sci 2000; 25: 257\u2013260.","journal-title":"Trends Biochem Sci"},{"key":"BFleu2015153_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/bbrc.1999.1454","volume":"263","author":"S Kumar","year":"1999","unstructured":"Kumar S, Jiang MS, Adams JL, Lee JC . Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 1999; 263: 825\u2013831.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2015153_CR20","doi-asserted-by":"publisher","first-page":"19472","DOI":"10.1074\/jbc.M414221200","volume":"280","author":"Y Kuma","year":"2005","unstructured":"Kuma Y, Sabio G, Bain J, Shpiro N, Marquez R, Cuenda A . BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem 2005; 280: 19472\u201319479.","journal-title":"J Biol Chem"},{"key":"BFleu2015153_CR21","doi-asserted-by":"publisher","first-page":"16475","DOI":"10.1021\/bi051714v","volume":"44","author":"JE Sullivan","year":"2005","unstructured":"Sullivan JE, Holdgate GA, Campbell D, Timms D, Gerhardt S, Breed J et al. Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase. Biochemistry 2005; 44: 16475\u201316490.","journal-title":"Biochemistry"},{"key":"BFleu2015153_CR22","doi-asserted-by":"publisher","first-page":"e54181","DOI":"10.1371\/journal.pone.0054181","volume":"8","author":"D He","year":"2013","unstructured":"He D, Zhao XQ, Chen XG, Fang Y, Singh S, Talele TT et al. BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells. PLoS One 2013; 8: e54181.","journal-title":"PLoS One"},{"key":"BFleu2015153_CR23","doi-asserted-by":"publisher","first-page":"11011","DOI":"10.1073\/pnas.0504952102","volume":"102","author":"TA Carter","year":"2005","unstructured":"Carter TA, Wodicka LM, Shah NP, Velasco AM, Fabian MA, Treiber DK et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc Natl Acad Sci USA 2005; 102: 11011\u201311016.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015153_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cgh.2005.11.013","volume":"4","author":"S Schreiber","year":"2006","unstructured":"Schreiber S, Feagan B, D'Haens G, Colombel JF, Geboes K, Yurcov M et al. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4: 325\u2013334.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFleu2015153_CR25","first-page":"1684","volume":"63","author":"JA Aguirre-Ghiso","year":"2003","unstructured":"Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L ERK . (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003; 63: 1684\u20131695.","journal-title":"Cancer Res"},{"key":"BFleu2015153_CR26","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/bjc.2011.445","volume":"105","author":"Y Farnoushi","year":"2011","unstructured":"Farnoushi Y, Cipok M, Kay S, Jan H, Ohana A, Naparstek E et al. Rapid in vivo testing of drug response in multiple myeloma made possible by xenograft to turkey embryos. Br J Cancer 2011; 105: 1708\u20131718.","journal-title":"Br J Cancer"},{"key":"BFleu2015153_CR27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.leukres.2009.02.009","volume":"33","author":"I Grinberg","year":"2009","unstructured":"Grinberg I, Reis A, Ohana A, Taizi M, Cipok M, Tavor S et al. Engraftment of human blood malignancies to the turkey embryo: a robust new in vivo model. Leuk Res 2009; 33: 1417\u20131426.","journal-title":"Leuk Res"},{"key":"BFleu2015153_CR28","doi-asserted-by":"publisher","first-page":"e1000475","DOI":"10.1371\/journal.pbio.1000475","volume":"8","author":"RA Dalloul","year":"2010","unstructured":"Dalloul RA, Long JA, Zimin AV, Aslam L, Beal K, Blomberg Le A et al. Multi-platform next-generation sequencing of the domestic turkey (Meleagris gallopavo: genome assembly and analysis. PLoS Biol 2010; 8: e1000475.","journal-title":"PLoS Biol"},{"key":"BFleu2015153_CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG . The molecular genetic makeup of acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program 2012; 2012: 389\u2013396.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"BFleu2015153_CR30","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1038\/bcj.2013.48","volume":"3","author":"Y Linka","year":"2013","unstructured":"Linka Y, Ginzel S, Kruger M, Novosel A, Gombert M, Kremmer E et al. The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods. Blood Cancer J 2013; 3: e151.","journal-title":"Blood Cancer J"},{"key":"BFleu2015153_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/leu.2010.277","volume":"25","author":"M Zaliova","year":"2011","unstructured":"Zaliova M, Madzo J, Cario G, Trka J . Revealing the role of TEL\/AML1 for leukemic cell survival by RNAi-mediated silencing. Leukemia 2011; 25: 313\u2013320.","journal-title":"Leukemia"},{"key":"BFleu2015153_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1150648","volume":"319","author":"D Hong","year":"2008","unstructured":"Hong D, Gupta R, Ancliff P, Atzberger A, Brown J, Soneji S et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008; 319: 336\u2013339.","journal-title":"Science"},{"key":"BFleu2015153_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.stem.2009.04.019","volume":"5","author":"JW Schindler","year":"2009","unstructured":"Schindler JW, Van Buren D, Foudi A, Krejci O, Qin J, Orkin SH et al. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 2009; 5: 43\u201353.","journal-title":"Cell Stem Cell"},{"key":"BFleu2015153_CR34","doi-asserted-by":"publisher","first-page":"e26348","DOI":"10.1371\/journal.pone.0026348","volume":"6","author":"G Fuka","year":"2011","unstructured":"Fuka G, Kauer M, Kofler R, Haas OA, Panzer-Grumayer R . The leukemia-specific fusion gene ETV6\/RUNX1 perturbs distinct key biological functions primarily by gene repression. PLoS One 2011; 6: e26348.","journal-title":"PLoS One"},{"key":"BFleu2015153_CR35","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/leu.2011.322","volume":"26","author":"G Fuka","year":"2012","unstructured":"Fuka G, Kantner HP, Grausenburger R, Inthal A, Bauer E, Krapf G et al. Silencing of ETV6\/RUNX1 abrogates PI3K\/AKT\/mTOR signaling and impairs reconstitution of leukemia in xenografts. Leukemia 2012; 26: 927\u2013933.","journal-title":"Leukemia"},{"key":"BFleu2015153_CR36","first-page":"3159","volume":"9","author":"MP Kamps","year":"1994","unstructured":"Kamps MP, Wright DD . Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene 1994; 9: 3159\u20133166.","journal-title":"Oncogene"},{"key":"BFleu2015153_CR37","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1210\/me.2004-0528","volume":"19","author":"AL Miller","year":"2005","unstructured":"Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 2005; 19: 1569\u20131583.","journal-title":"Mol Endocrinol"},{"key":"BFleu2015153_CR38","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1038\/cddis.2012.89","volume":"3","author":"N Heidari","year":"2012","unstructured":"Heidari N, Miller AV, Hicks MA, Marking CB, Harada H . Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells. Cell Death Dis 2012; 3: e349.","journal-title":"Cell Death Dis"},{"key":"BFleu2015153_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jb\/mvp213","volume":"147","author":"WH Lee","year":"2010","unstructured":"Lee WH, Liu FH, Lee YL, Huang HM . Interferon-alpha induces the growth inhibition of human T-cell leukaemia line Jurkat through p38alpha and p38beta. J Biochem 2010; 147: 645\u2013650.","journal-title":"J Biochem"},{"key":"BFleu2015153_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4049\/jimmunol.170.1.252","volume":"170","author":"T Taguchi","year":"2003","unstructured":"Taguchi T, Kiyokawa N, Mimori K, Suzuki T, Sekino T, Nakajima H et al. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol 2003; 170: 252\u2013260.","journal-title":"J Immunol"},{"key":"BFleu2015153_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1084\/jem.20110580","volume":"208","author":"C Shochat","year":"2011","unstructured":"Shochat C, Tal N, Bandapalli OR, Palmi C, Ganmore I, te Kronnie G et al. Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 2011; 208: 901\u2013908.","journal-title":"J Exp Med"},{"key":"BFleu2015153_CR42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ng.924","volume":"43","author":"PP Zenatti","year":"2011","unstructured":"Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011; 43: 932\u2013939.","journal-title":"Nat Genet"},{"key":"BFleu2015153_CR43","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1182\/blood-2012-05-432252","volume":"121","author":"A Shieh","year":"2013","unstructured":"Shieh A, Ward AF, Donlan KL, Harding-Theobald ER, Xu J, Mullighan CG et al. Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood 2013; 121: 4884\u20134893.","journal-title":"Blood"},{"key":"BFleu2015153_CR44","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1535-7163.MCT-09-0408","volume":"8","author":"J Cui","year":"2009","unstructured":"Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y et al. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Mol Cancer Ther 2009; 8: 3214\u20133222.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2015153_CR45","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/leu.2008.79","volume":"22","author":"F Chiarini","year":"2008","unstructured":"Chiarini F, Del Sole M, Mongiorgi S, Gaboardi GC, Cappellini A, Mantovani I et al. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 2008; 22: 1106\u20131116.","journal-title":"Leukemia"},{"key":"BFleu2015153_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3324\/haematol.12098","volume":"93","author":"MT Scupoli","year":"2008","unstructured":"Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G et al. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12\/CXCR4 axis and the NF-kappaB and JNK\/AP-1 pathways. Haematologica 2008; 93: 524\u2013532.","journal-title":"Haematologica"},{"key":"BFleu2015153_CR47","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/carcin\/bgm294","volume":"29","author":"KT Leung","year":"2008","unstructured":"Leung KT, Li KK, Sun SS, Chan PK, Ooi VE, Chiu LC . Activation of the JNK pathway promotes phosphorylation and degradation of BimEL\u2014a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. Carcinogenesis 2008; 29: 544\u2013551.","journal-title":"Carcinogenesis"},{"key":"BFleu2015153_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2141.2008.06980.x","volume":"140","author":"E Forestier","year":"2008","unstructured":"Forestier E, Heyman M, Andersen MK, Autio K, Blennow E, Borgstrom G et al. Outcome of ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival. Br J Haematol 2008; 140: 665\u2013672.","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:30:11Z","timestamp":1648744211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFleu2015153"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.153","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]},"assertion":[{"value":"17 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}